Global Scientific & Value Content and Implementation - Payor
MSD
Summary
The Director, Global Scientific & Value Content (Dir GSVC) position resides in the Value & Implementation (V&I) organization. This position will report to the Sr Director, Payor Team Lead, GSVC. The role has several key responsibilities within the V&I team and will support the Oncology portfolio.
Job description
Role Summary
The Director, Global Scientific & Value Content (Dir GSVC) position resides in the Value & Implementation (V&I) organization. This position will report to the Sr Director, Payor Team Lead, GSVC. The role has several key responsibilities within the V&I team and will support the Oncology portfolio.
Responsibilities and Primary Activities
Annual Planning and Content Development: Creates, adapts and prioritizes annual GSVC content Plan(s) aligned with V&I Plan and informed through insights and feedback from key internal stakeholders cross-functionally and worldwide. Executes GSVC Plans that include, but are not limited to, medical information letters, verbal response documents (VRD), infographics, disease- and product-related slide decks, global congress medical booth materials, and digital/web-based medical content. Develop oncology payer and health systems scientific content, applying knowledge of payer landscape (US and global) to support launches, anticipated approvals, guideline updates, Phase 3 data releases, non-interventional real-world evidence, Health Care Economic Information (HCEI), and relevant competitive intelligence. Ensures appropriate stakeholders are engaged in the development, review and approval of GSVC materials. For the Payor team, this includes attending CRT prioritization, review and approval of proactive content as well as Medical Legal Review (MLR) of reactive content. Maintains awareness of scientific, policy, methodological, and competitive developments relevant to oncology and health systems. Coordinates with Global Expert Management and Strategy Consulting & Medical Education (GEMS) to provide appropriate coverage for group input meetings (GIMs) relevant to TA and participates as medical writer for GIMs aligned to priorities and responsibilities.
Resource Implementation: Partners with V&I OR, Payer Access Strategy Leads (PASLs), and Global Scientific Training (GST) to translate complex scientific, value, and outcomes evidence into content with clear field-ready curricula, and practical learning experiences. Establish approval-readiness milestones, coordinate implementation timelines, and lead the timely deployment of scientific training on key GSVC payor content, aligned with portfolio and field priorities by coordinating with Knowledge Management, V&I Global Medical and Value Capabilities (V&I GMVC), Global Scientific Training (GST), and the Field Medical organization. Support structured onboarding for new Payer & Health Systems colleagues engaging across oncology products, evidence, and payer stakeholder types. Coordinate the maintenance, updating, retirement, reuse, and redeployment of training resources to keep materials aligned with evolving evidence, approved resources, guidelines, and field needs. Support performance measures related to launch readiness, onboarding effectiveness, mastery of scientific exchange, and training completion.
Cross-function Collaboration and Leadership: Serves as a therapeutic-area subject-matter expert, leading initiatives that shape V&I plan strategy and address external customer needs by translating complex scientific, clinical, HEOR/HCEI, guideline, and access-related information into scientific content and actionable field resources. Drives the solution to complex problems through identification of innovative solutions and is a go-to person within the core GSVC team for colleagues across stakeholder departments and demonstrated ability to lead across matrixed teams, influence without direct authority, align stakeholders, and manage multiple priorities. Work independently and collaboratively while demonstrating Integrity, Precision, Motivational Ambition, Respect, and Inclusion. Leads departmental initiatives that impact GSVC process improvements, fostering innovation and cross-functional collaborations. Endorses change to enable GSVC to successfully adopt transitions that drive better individual and organizational performance and outcomes. Mentors newly hired V&I GMVC team members; facilitate onboarding and training of core functions for P3/P4 GSVC team members; and assist GSVC Team Lead in continued development of the team.
Requirements
- MD/PharmD/PhD
- Minimum of five years of relevant Medical Affairs experience (e.g., medical communications, medical information, medical liaison, publications)
- Extensive knowledge of healthcare systems, payor process/environment and clinical pathways
- Relevant working experience in Medical Affairs, Outcomes Research, health services research, epidemiology, health technology assessment, or a related field in the pharmaceutical industry
- Strong scientific writing and communication skills
- Proven strengths in strategic thinking, project management, innovation, prioritization, and complex problem-solving across cross-functional environments
- Knowledge of manufacturer-initiated scientific communications guidance, including applicable frameworks such as FDAMA 114, Scientific Information on Unapproved Uses (SIUU), and Academy of Managed Care Pharmacy (AMCP) Real-World Evidence (RWE) guidance
- Commitment to scientifically accurate, medically appropriate, and compliant communication
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Paid Holidays
- Vacation
- Compassionate Leave
- Sick Days
- Annual Bonus
- Long-term Incentive
Company overview
MSD, known as Merck Sharp & Dohme outside the United States and Canada, is a global research-intensive biopharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891, the company has established itself as one of the world's leading pharmaceutical corporations with a rich history spanning over 130 years. MSD operates as the international division of Merck & Co., Inc., focusing on the discovery, development, manufacturing, and marketing of innovative medicines, vaccines, biologic therapies, and animal health products. The company's extensive portfolio includes groundbreaking treatments in oncology, infectious diseases, cardiology, diabetes, and vaccines, with notable products such as Keytruda (pembrolizumab) for cancer immunotherapy, Gardasil for HPV prevention, and Januvia for diabetes management. MSD maintains a strong commitment to research and development, investing significantly in scientific innovation to address unmet medical needs worldwide. With approximately 75,000 employees globally, the company operates through four main segments: pharmaceuticals, animal health, healthcare services, and strategic alliances. MSD's mission centers on using leading-edge science to save and improve lives around the world, guided by the principle that medicine is for people, not profits.